Thomas Temme Email & Phone Number

Berlin, DE

Berlin, Germany

Focus: Securing patient access and reimbursement for Krystal Biotech's pipeline products in Germany & Austria, focusing initially on rare disease epidermolysis bullosa.

Berlin, Deutschland

Focus: Responsible for pricing and reimbursement of BridgeBio's pipeline products in Germany, Austria & Switzerland until https://investor.bridgebio.com/news-releases/news-release-details/bridgebio-pharma-and-bayer-announce-european-licensing-agreement/

Berlin, Germany

Focus: Supporting established and geographically expanding biotechs and pharmaceutical companies in bringing their products to patients in Europe. Preparing pricing & reimbursement assessments, strategies, applications and negotiations. Engaging with key external stakeholders from patients, policy, media.

Berlin, Germany

Focus: Integrating Oxbryta and Sickle Cell Disease into Pfizer Germany in access and external affairs related functions and finalizing Oxbryta’s AMNOG HTA negotiation. Promoting Pfizer’s leadership in sickle cell disease to internal and external stakeholders. Transitory role after GBT acquisition.

Berlin, Germany

Focus: Enabling access of sickle cell disease patients to medical care and GBT's treatments in Germany (AMNOG). Working with patients, media, politics and science to understand and address care deficits in sickle cell disease. Supporting market research and planning, forecasting and the local supply chain.

Berlin

Focus: Promoting Takeda and Takeda’s value driven business with key external stakeholders ranging from patient organizations, health insurances, physician associations, hospital pharmacies / purchasing groups and wholesalers over to politics; engaging in health policy and administration and securing contracts with payors and purchasers; heading a.

Berlin Area, Germany

Focus: Securing adequate pricing and reimbursement for all marketed and upcoming Shire products in Germany, Austria and Switzerland, including responsibility for all HTA processes (e.g. AMNOG) from dossier preparation to negotiation; promoting care for rare diseases and Shire’s interests in the public and in the political arena. Shire is now part of Takeda.

Berlin Area, Germany

Focus: Securing adequate pricing and reimbursement for all marketed and upcoming Shire products in Germany, Austria and Switzerland, including responsibility for all HTA processes (e.g. AMNOG) from dossier preparation to negotiation; promoting care for rare diseases and Shire’s interests in the public and in the political arena.

Hannover, Germany

As a project leader in a boutique strategy consulting firm in healthcare, I worked with several of the largest public and private health insurance companies in Germany in large care management and cost reduction projects. Since 2011, I mainly worked in or led several projects on European market access and pricing for medtech and pharmaceutical innovations.

Berlin Area, Germany

Focus: Benchmarking and comparative studies in the utilities sector; development of municipal performance measurement systems. (Company went out of business)

Kreisfreie Stadt Aachen Area, Germany

Business Intelligence Manager and later Business Development Manager at public biopharmaceutical start-up company PAION in Aachen, Germany. Focus: Project valuation; project management; licensing and due diligence; primary and secondary market research; started as trainee in the Project Management department.

Master Of Arts (M.A.), Sociology

Master Of Business Administration (Mba)

Full time MBA program “European Management” at the Berlin School of Economics and Law (AMBA and FIBAA accredited); graduation with a focus.

Academic Exchange, Sociology

Studied at the University of Urbino (Italy). Development work at the tele-didactical system mytd

Academic Exchange, Sociology